Seminars in Nuclear Medicine
Volume 36, Issue 1 , Pages 3-15, January 2006

Update of Renal Imaging

  • Nicolas Grenier, MD

      Affiliations

    • Service d’Imagerie Diagnostique et Interventionnelle de l’Adulte, Groupe Hospitalier Pellegrin, Bordeaux cedex, France.
    • ERT CNRS “Imagerie Moléculaire et Fonctionnelle,” Université Victor Segalen-Bordeaux 2, Bordeaux, France.
    • Corresponding Author InformationAddress reprint requests to Nicolas Grenier, MD, Service d’Imagerie Diagnostique et Interventionnelle de l’Adulte, Groupe Hospitalier Pellegrin, Place Amélie Raba Léon, 33,076 - Bordeaux cedex, France.
  • ,
  • Olivier Hauger, MD, PhD

      Affiliations

    • Service d’Imagerie Diagnostique et Interventionnelle de l’Adulte, Groupe Hospitalier Pellegrin, Bordeaux cedex, France.
    • ERT CNRS “Imagerie Moléculaire et Fonctionnelle,” Université Victor Segalen-Bordeaux 2, Bordeaux, France.
  • ,
  • Angela Cimpean, MD

      Affiliations

    • Service d’Imagerie Diagnostique et Interventionnelle de l’Adulte, Groupe Hospitalier Pellegrin, Bordeaux cedex, France.
  • ,
  • Vinçent Pérot, MD

      Affiliations

    • Service d’Imagerie Diagnostique et Interventionnelle de l’Adulte, Groupe Hospitalier Pellegrin, Bordeaux cedex, France.

Significant technical improvements have allowed the use of radiological techniques to play a growing role in the imaging of renal diseases. Noninvasive ultrasound methods (ie, sonography and Doppler) are now positioned as first-line methods for the evaluation of renovascular diseases. Multidetector computed tomography is able to provide high spatial resolution images of the kidneys and renal arterial vessels. Magnetic resonance imaging, which provides higher signal-to-noise ratio and higher spatial and/or temporal resolution, can display both morphological information about renal parenchyma and vessels and functional data, including perfusion, filtration, diffusion, or oxygenation. In renovascular diseases, these techniques have the potential to drive new strategies, including Doppler sonography as a first-line method, followed by computed tomography angiography or magnetic resonance angiography, depending mainly on renal function. Imaging of parenchymal renal diseases is developing toward more quantitative (volumetric and functional measurements) and more specific (through in vivo cell targeting) acquisitions for obtaining the adequate information on tissue characteristics relevant either for diagnosis or for prognosis or treatment follow-up.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0001-2998(05)00048-6

doi:10.1053/j.semnuclmed.2005.08.001

Seminars in Nuclear Medicine
Volume 36, Issue 1 , Pages 3-15, January 2006